Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment

Affiliations

• 1 School of Medicine, Hubei Polytechnic University, Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Huangshi, 435003, China.
• 2 School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China.
• 3 Department of Cardiology, The Sixth Affiliated Hospital, South China University of Technology, Nanhai people's Hospital, Foshan, Guangdong, 528200, China.
• 4 School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China. liusw@smu.edu.cn.
• 5 School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, China. jchen21@smu.edu.cn.
• # Contributed equally.